|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/404 | (2006.01) |
| A61K 31/428 | (2006.01) | ||
| A61K 31/426 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61K 31/498 | (2006.01) | ||
| A61P 11/02 | (2006.01) | ||
| A61P 11/06 | (2006.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 19/02 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 403/06 | (2006.01) | ||
| C07D 417/06 | (2006.01) | ||
| C07D 209/20 | (2006.01) |
| (11) | Number of the document | 1682121 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04768943.5 |
| Date of filing the European patent application | 2004-10-19 | |
| (97) | Date of publication of the European application | 2006-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-12 |
| (46) | Date of publication of the claims translation | 2009-11-25 |
| (86) | Number | PCT/GB2004/004417 |
| Date | 2004-10-19 |
| (87) | Number | WO 2005/044260 |
| Date | 2005-05-19 |
| (30) | Number | Date | Country code |
| 0324763 | 2003-10-23 | GB |
| (72) |
MIDDLEMISS, David, GB
ASHTON, Mark, Richard, GB
BOYD, Edward Andrew, GB
BROOKFIELD, Frederick Arthur, GB
PETTIPHER, Eric, Roy, GB
WHITTAKER, Mark, GB
PALMER, Christopher, GB
HUNTER, Mick, GB
|
| (73) |
ATOPIX THERAPHEUTICS LIMITED,
265 Strand, London WC2R, 1HB,
GB
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CRTH2 antagonistų junginių panaudojimas gydyme |
| USE OF CRTH2 ANTAGONIST COMPOUNDS IN THERAPY |
| Payment date | Validity (years) | Amount | |
| 2021-10-04 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-10-19 |